G - Physics – 01 – N
Patent
G - Physics
01
N
195/33
G01N 33/60 (2006.01) C12N 9/00 (2006.01) C12Q 1/25 (2006.01)
Patent
CA 1094476
ABSTRACT OF THE DISCLOSURE A specific type of protein, which has been designated B-protein (Bucovaz-protein), is present in most serum of indivi- duals with cancer. The B-protein interacts with a low molecular weight protein component, which is released by the coenzyme A- synthesizing protein complex (Coa-SPC) of Bakers' yeast during the course of CoA synthesis. This low molecular weight protein, for purposes of identification, is referred to as binding protein. The binding protein has a molecular weight of 10,000 to 15,000. Interaction of radioactively labeled binding protein of CoA-SPC with the B-protein of serum provides a marker for the detection of cancer. Of 3005 serums assayed, which included 908 patients diagnosed as having cancer, the B-protein assay agreed with the clinical diagnosis in more than 89% of the cases.
276356
Bucovaz Edsel T.
Morrison John C.
Morrison William C.
Whybrew Walter D.
Meredith & Finlayson
Research Corporation
LandOfFree
Application of protein - protein interaction as an assay for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Application of protein - protein interaction as an assay for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Application of protein - protein interaction as an assay for... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-258359